Solid cancer incidence in atomic bomb survivors: 1958-1998

Radiation Research

Volumn 168, Issue 1, 2007, Pages 1-64

  Preston, D L ^a   Ron, E ^b   Tokuoka, S ^c   Funamoto, S ^c   Nishi, N ^c   Soda, M ^c   Mabuchi, K ^b   Kodama, K ^c  

^a Hirosoft International Corporation   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POISON;

ADENOCARCINOMA; ADOLESCENT; ADULT; ADULTHOOD; AGED; ARTICLE; ATOMIC BOMB; ATOMIC BOMB SURVIVOR; BLADDER CANCER; BLOOD; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CHILD; COHORT ANALYSIS; COLON; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; DOSIMETRY; ESOPHAGUS CANCER; FEMALE; GALLBLADDER CANCER; GENDER; GENITAL TRACT CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY PELVIS CARCINOMA; LARYNX CANCER; LIFE; LIFESPAN; LIP CANCER; LIVER CANCER; LIVER METASTASIS; LUNG CANCER; MALE; MEDICAL INFORMATION; MELANOMA; MOUTH CANCER; NOSE CAVITY CANCER; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION EXPOSURE; RADIATION RESPONSE; RECTUM CANCER; RISK FACTOR; SALIVARY GLAND CANCER; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; TONGUE CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; AGE DISTRIBUTION; ATOMIC WARFARE; FOLLOW UP; INCIDENCE; INFANT; JAPAN; MIDDLE AGED; NEOPLASM; NEWBORN; PRESCHOOL CHILD; SEXUAL DEVELOPMENT; STATISTICS; SURVIVOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; NUCLEAR WARFARE; RISK FACTORS; SEX CHARACTERISTICS; SURVIVORS;

EID: 34548581922     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0763.1     Document Type: Article

References (127)

1. K. Mabuchi, M. Soda, E. Ron, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki, D. L. Preston and D. E. Thompson, Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat. Res. 137 (Suppl.), S1-S16 (1994).
2. D. E. Thompson, K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki and D. L. Preston, Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat. Res. 137 (Suppl.), S17-S67 (1994).
3. D. L. Preston, S. Kusumi, M. Tomonaga, S. Izumi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy, T. Matsuo and K. Mabuchi, Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat. Res. 137 (Suppl.), S68-S97 (1994).
4. E. Ron, D. L. Preston, K. Mabuchi, D. E. Thompson and M. Soda, Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality. Radiat. Res. 137 (Suppl.), S98-S112 (1994); Erratum, Radiat. Res. 139, 129 (1994).
5. D. A. Pierce and D. L. Preston, Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat. Res. 154, 178-186 (2000).
6. E. Ron, D. L. Preston, M. Kishikawa, T. Kobuke, M. Iseki, S. Tokuoka, M. Tokunaga and K. Mabuchi, Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes Control 9, 393-401 (1998).
7. C. E. Land, T. Saku, Y. Hayashi, O. Takahara, H. Matsuura, S. Tokuoka, M. Tokunaga and K. Mabuchi, Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk. Radiat. Res. 146, 28-36 (1996); Erratum, Radiat. Res. 146, 356 (1996).
8. C. E. Land, M. Tokunaga, K. Koyama, M. Soda, D. L. Preston, I. Nishimori and S. Tokuoka, Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat. Res. 160, 707-717 (2003).
9. J. B. Cologne, S. Tokuoka, G. W. Beebe, T. Fukuhara and K. Mabuchi, Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. Radiat. Res. 152, 364-373 (1999).
10. G. B. Sharp, J. B. Cologne, T. Fukuhara, H. Itakura, M. Yamamoto and S. Tokuoka, Temporal changes in liver cancer incidence rates in Japan: Accounting for death certificate inaccuracies and improving diagnostic techniques. Int. J. Cancer 93, 751-758 (2001).
11. T. Fukuhara, G. B. Sharp, T. Mizuno, H. Itakura, M. Yamamoto, M. Tokunaga, S. Tokuoka, J. B. Cologne, Y. Fujita and K. Mabuchi, Liver cancer in atomic-bomb survivors: histological characteristics and relationships to radiation and hepatitis B and C viruses. J. Radiat. Res. (Tokyo) 42, 117-130 (2001).
12. D. L. Preston, A. Mattsson, E. Holmberg, R. Shore, N. G. Hildreth and J. D. Boice, Jr., Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiat. Res. 158, 220-235 (2002).
13. D. A. Pierce, G. B. Sharp and K. Mabuchi, Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors. Radiat. Res. 159, 511-520 (2003).
14. D. L. Preston, E. Ron, S. Yonehara, T. Kobuke, H. Fujii, M. Kishikawa, M. Tokunaga, S. Tokuoka and K. Mabuchi, Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J. Natl. Cancer Inst. 94, 1555-1563 (2002).
15. S. Yonehara, A. V. Brenner, M. Kishikawa, P. D. Inskip, D. L. Preston, E. Ron, K. Mabuchi and S. Tokuoka, Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995. Cancer 101, 1644-1654 (2004).
16. E. Ron, T. Ikeda, D. L. Preston and S. Tokuoka, Male breast cancer incidence among atomic bomb survivors. J. Natl. Cancer Inst. 97, 603-605 (2005).
17. M. Kishikawa, K. Koyama, M. Iseki, T. Kobuke, S. Yonehara, M. Soda, E. Ron, M. Tokunaga, D. L. Preston and S. Tokuoka, Histologic characteristics of skin cancer in Hiroshima and Nagasaki: Background incidence and radiation effects. Int. J. Cancer 117, 363-369 (2005).
18. R. W. Young and G. D. Kerr, Eds., Reassessment of the Atomic-Bomb Radiation Dosimetry for Hiroshima and Nagasaki: Dosimetry System 2002. Radiation Effects Research Foundation, Hiroshima, 2005.
19. D. L. Preston, D. A. Pierce, Y. Shimizu, H. M. Cullings, S. Fujita, S. Funamoto and K. Kodama, Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 162, 377-389 (2004).
20. D. L. Preston, Y. Shimizu, D. A. Pierce, A. Suyama and K. Mabuchi, Studies of mortality of atomic bomb survivors. Report 13: Solid 0cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160, 381-407 (2003).
21. D. A. Pierce, Y. Shimizu, D. L. Preston, M. Vaeth and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer: 1950-1990. Radiat. Res. 146, 1-27 (1996).
22. Y. Shimizu, D. A. Pierce, D. L. Preston and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, part II. Non-cancer mortality: 1950-1990. Radiat. Res. 152, 374-389 (1999).
23. J. B. Cologne and D. L. Preston, Longevity of atomic-bomb survivors. Lancet 356, 303-307 (2000).
24. WHO, International Classification of Diseases for Oncology (ICD-O-3). World Health Organization, Geneva, 2000.
25. R. Sposto and D. L. Preston, Correcting for Catchment Area Non-residency in Studies Based on Tumor Registry Data. Radiation Effects Research Foundation, Hiroshima, 1992.
26. ICRP, 1990 Recommendations of the International Commission on Radiological Protection. Publication 60, Annals of the ICRP, Vol. 21, No. 1-3, Pergamon Press, Oxford, 1991
27. ICRU, Quantities and Units in Radiation Protection Dosimetry. Report 51, International Commission on Radiation Units and Measurements, Bethesda, MD, 1993.
28. D. A. Pierce, D. O. Stram and M. Vaeth, Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat. Res. 123, 275-284 (1990).
29. H. M. Cullings, S. Fujita, S. Funamoto, E. J. Grant, G. D. Kerr and D. L. Preston, Dose estimation for atomic bomb survivor studies: Its evolution and present status. Radiat. Res. 166, 219-254 (2006).
30. D. Clayton and M. Hills, Statistical Methods in Epidemiology. Oxford University Press, New York, 1993.
31. N. E. Breslow and N. E. Day, The Design and Analysis of Cohort Studies. International Agency for Research on Cancer, Lyon, 1988.
32. D. L. Preston, J. H. Lubin, D. A. Pierce and M. E. McConney, Epicure Users Guide. Hirosoft International Corporation, Seattle, WA, 1993.
33. W. Ajiki, H. Tsukuma and A. Oshima, Cancer incidence and incidence rates in Japan in 1999: Estimates based on data from 11 population-based cancer registries. Jpn. J. Clin. Oncol. 34, 352-356 (2004).
34. D. M. Parkin, S. L. Whelan, J. Ferlay, L. Teppo and D. B. Thomas, Eds., Cancer Incidence in Five Continents, Vol. VIII. IARC Scientific Publications No. 155, IARC, Lyon, 2002.
35. National Academy of Sciences, Committee on the Biological Effects of Radiation, Health Risks From Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. National Academies Press, Washington, DC, 2005.
36. NCRP, Uncertainties in Fatal Cancer Risk Estimates Used in Radiation Protection. Report 126, National Council on Radiation Protection and Measurements, Bethesda, MD, 1997.
37. UNSCEAR, Sources and Effects of Ionizing Radiation: 2000 Report to the General Assembly, with Scientific Annexes, Vol. II: Effects. United Nations, New York, 2000.
38. Research group for population-based cancer registration in Japan, Cancer incidence and incidence rates in Japan in 1998: Estimates based on data from 12 population-based cancer registries. Jpn. J. Clin. Oncol. 33, 241-245 (2003).
39. E. Petridou, A. I. Zavras, D. Lefatzis, N. Dessypris, G. Laskaris, G. Dokianakis, J. Segas, C. W. Douglas, S. R. Diehl and D. Trichopoulos, The role of diet and specific micronutrients in the etiology of oral carcinoma. Cancer 94, 2981-2988 (2002).
40. W. J. Blot, J. K. McLaughlin, D. M. Winn, D. F. Austin, R. S. Greenberg, S. Preston-Martin, L. Bernstein, J. B. Schoenberg, A. Stemhagen and J. F. Fraumeni, Jr., Smoking and drinking in relation to oral and pharyngeal cancer. Canter Res. 48, 3282-3287 (1988).
41. W. J. Blot, J. K. McLaughlin, S. S. Devesa and J. F. Fraumeni, Jr., Cancers of the oral cavity and pharynx. In Cancer Epidemiology and Prevention (D. Schottenfeld and J. F. Fraumeni, Jr., Eds.), pp. 666-680. Oxford University Press, New York, 1996.
42. M. R. Spitz, B. C. Tilley, J. G. Batsakis, J. M. Gibeau and G. R. Newell, Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer 54, 1854-1859 (1984).
43. S. Preston-Martin, D. C. Thomas, S. C. White and D. Cohen, Prior exposure to medical and dental x-rays related to tumors of the parotid gland. J. Natl. Cancer Inst. 80, 943-949 (1988).
44. J. L. Belsky, N. Takeichi, T. Yamamoto, R. W. Cihak, F. Hirose, H. Ezaki, S. Inoue and W. J. Blot, Salivary gland neoplasms following atomic radiation: Additional cases and reanalysis of combined data in a fixed population, 1957-1970. Cancer 35, 555-559 (1975).
45. T. Saku, Y. Hayashi, O. Takahara, H. Matsuura, M. Tokunaga, M. Tokunaga, S. Tokuoka, M. Soda, K. Mabuchi and C. E. Land, Salivary gland tumors among atomic bomb survivors, 1950-1987. Cancer 79, 1465-1475 (1997).
46. J. Lagergren, Adenocarcinoma of oesophagus: What exactly is the size of the problem and who is at risk? Gut 54 (Suppl. 1), i1-i5 (2005).
47. U. Ribeiro, Jr., A. V. Safatle-Ribeiro, M. R. Clarke and M. C. Posner, Primary malignant melanoma of the esophagus. Am. J. Gastroenterol. 91, 1048-1049 (1996).
48. L. M. Brown and S. S. Devesa, Epidemiologic trends in esophageal and gastric cancer in the United States. Surg. Oncol. Clin. N. Am. 11, 235-256 (2002).
49. H. Tsukuma, W. Ajiki, A. Ioka and A. Oshima, Survival of cancer patients diagnosed between 1993 and 1996: A collaborative study of population-based cancer registries in Japan. Jpn. J. Clin. Oncol. 36, 602-607 (2006).
50. L. S. Engel, W. H. Chow, T. L. Vaughan, M. D. Gammon, H. A. Risen, J. L. Stanford, J. B. Schoenberg, S. T. Mayne, R. Dubrow and J. F. Fraumeni, Jr., Population attributable risks of esophageal and gastric cancers. J. Natl. Cancer Inst. 95, 1404-1413 (2003).
51. M. P. Little, Cancer after exposure to radiation in the course of treatment for benign and malignant disease. Lancet Oncol. 2, 212-220 (2001).
52. L. B. Zablotska, A. Chak, A. Das and A. I. Neugut, Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am. J. Epidemiol. 161, 330-337 (2005).
53. P. Correa, Bacterial infections as a cause of cancer. J. Natl. Cancer Inst. 95, E3 (2003).
54. T. Kobayashi, S. Kikuchi, Y. Lin, K. Yagyu, Y. Obata, A. Ogihara, A. Hasegawa, K. Miki, E. Kaneko and H. Tenjin, Trends in the incidence of gastric cancer in Japan and their associations with Helicobacter pylori infection and gastric mucosal atrophy. Gastric Cancer 7, 233-239 (2004).
55. Z. A. Carr, R. A. Kleinerman, M. Stovall, R. M. Weinstock, M. L. Griem and C. E. Land, Malignant neoplasms after radiation therapy for peptic ulcer. Radiat. Res. 157, 668-677 (2002).
56. J. D. Boice, Jr., G. Engholm, R. A. Kleinerman, M. Blettner, M. Stovall, H. Lisco, W. C. Moloney, D. F. Austin, A. Bosch and B. McMahon, Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat. Res. 116, 3-55 (1988).
57. A. M. Nomura, Stomach cancer. In Cancer Epidemiology and Prevention (D. Schottenfeld and J. F. Fraumeni, Jr., Eds.), pp. 707-724. Oxford University Press, New York, 1996.
58. J. R. Kelley and J. M. Duggan, Gastric cancer epidemiology and risk factors. J. Clin. Epidemiol. 56, 1-9 (2003).
59. S. Nakaji, T. Umeda, T. Shimoyama, K. Sugawara, K. Tamura, S. Fukuda, J. Sakamoto and S. Parodi, Environmental factors affect colon carcinoma and rectal carcinoma in men and women differently. Int. J. Colorectal Dis. 18, 481-486 (2003).
60. S. Kono, Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J. Cancer Prev. 13, 127-132 (2004).
61. H. Y. Yiu, A. S. Whittemore and A. Shibata, Increasing colorectal cancer incidence rates in Japan. Int. J. Cancer 109, 777-781 (2004).
62. P. D. Inskip, R. R. Monson, J. K. Wagoner, M. Stovall, F. G. Davis, R. A. Kleinerman and J. D. Boice, Jr., Cancer mortality following radium treatment for uterine bleeding. Radiat. Res. 123, 331-344 (1990).
63. M. Lundell and L. E. Holm, Risk of solid tumors after irradiation in infancy. Acta Oncol. 34, 727-734 (1995).
64. Y. Imamura and S. Mizuno, Mortality trends of rectal cancer in Japan: 1960-2000. Jpn. J. Clin. Oncol. 34, 107-108 (2004).
65. M. D. Levitt, D. M. Millar and J. O. Stewart, Rectal cancer after pelvic irradiation. J. R. Soc. Med. 83, 152-154 (1990).
66. H. Nakatsuka, Y. Shimizu, T. Yamamoto, I. Sekine, H. Ezaki, E. Tahara, M. Takahashi, T. Shimoyama, N. Mochinaga and M. Tomita, Colorectal cancer incidence among atomic bomb survivors, 1950-80. J. Radiat. Res. (Tokyo) 33, 342-361 (1992).
67. D. M. Parkin, F. Bray, J. Ferlay and P. Pisani, Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108 (2005).
68. H. Yoshizawa, Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: Projection to other countries in the foreseeable future. Oncology 62 (Suppl. 1), 8-17 (2002).
69. H. Tanaka, T. Hiyama, H. Tsukuma, Y. Okubo, H. Yamano, A. Kitada and I. Fujimoto, Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 5, 409-413 (1994).
70. K. Tanaka, T. Hirohata, K. Fukuda, A. Shibata, H. Tsukuma and T. Hiyama, Risk factors for hepatocellular carcinoma among Japanese women. Cancer Causes Control 6, 91-98 (1995).
71. G. B. Sharp, T. Mizuno, J. B. Cologne, T. Fukuhara, S. Fujiwara, S. Tokuoka and K. Mabuchi, Hepatocellular carcinoma among atomic bomb survivors: Significant interaction of radiation with hepatitis C virus infections. Int. J. Cancer 103, 531-537 (2003).
72. G. Randi, A. Altieri, S. Gallus, S. Franceschi, E. Negri, R. Talamini and C. La Vecchia, History of cirrhosis and risk of digestive tract neoplasms. Ann. Oncol. 16, 1551-1555 (2005).
73. M. Pandey, Risk factors for gallbladder cancer: A reappraisal. Eur. J. Cancer Prev. 12, 15-24 (2003).
74. S. Misra, A. Chaturvedi, N. C. Misra and I. D. Sharma, Carcinoma of the gallbladder. Lancet Oncol. 4, 167-176 (2003).
75. T. Matsuba, D. Qui and M. Kurosawa, Overview of epidemiology of bile duct and gallbladder cancer focusing on the JACC Study Group. J. Epidemiol. 2 S1 (Suppl.), 150-160 (2005).
76. L. B. Travis, M. Hauptmann, L. K. Gaul, H. H. Storm, M. B. Goldman, U. Nyberg, E. Berger, M. L. Janower, P. Hall and M. Andersson, Site-specific cancer incidence and mortality after cerebral angiography with radioactive Thorotrast. Radiat. Res. 160, 691-706 (2003).
77. IARC, Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carciongenic Risks to Humans, Vol. 83. International Agency for Research on Cancer, Lyon, 2004.
78. K. E. Andersen, J. D. Potter and T. M. Mack, Pancreatic cancer. In Cancer Epidemiology and Prevention (D. Schottenfeld and J. F. Fraumeni, Jr., Eds.), pp. 725-771. Oxford University Press, New York, 1996.
79. L. B. Travis, R. E. Curtis, H. Storm, P. Hall, E. Holowaty, F. E. Van Leeuwen, B. A. Kohler, E. Pukkala, C. F. Lynch and J. D. Boice, Jr., Risk of second malignant neoplasms among long-term survivors of testicular cancer. J. Natl. Cancer Inst. 89, 1429-1439 (1997).
80. Y. Imamura and T. Sobue, Cancer statistics digest. Mortality trend of colon, rectal, liver, "gallbladder and biliary tract" and pancreas cancer in Japan by birth cohort. Jpn. J. Clin. Oncol. 34, 491-493 (2004).
81. S. D. Stellman, T. Takezaki, L. Wang, Y. Chen, M. L. Citron, M. V. Djordjevic, S. Harlap, J. E. Muscat, A. I. Neugut and K. Aoki, Smoking and lung cancer risk in American and Japanese men: An international case-control study. Cancer Epidemiol. Biomarkers Prev. 10, 1193-1199 (2001).
82. S. Kaneko, K. B. Ishikawa, I. Yoshimi, T. Marugame, C. Hamashima, K. Kamo, S. Mizuno and T. Sobue, Projection of lung cancer mortality in Japan. Cancer Sci. 94, 919-923 (2003).
83. G. Pershagen, G. Akerblom, O. Axelson, B. Clavensjo, L. Damber, G. Desai, A. Enflo, F. Lagarde, H. Mellander and M. Svartengren, Residential radon exposure and lung cancer in Sweden. N. Engl. J. Med. 330, 159-164 (1994).
84. E. S. Gilbert, M. Stovall, M. Gospodarowicz, F. E. Van Leeuwen, M. Andersson, B. Glimelius, T. Joensuu, C. F. Lynch, R. E. Curtis and L. B. Travis, Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat. Res. 159, 161-173 (2003).
85. M. Ichihashi, K. Naruse, S. Harada, T. Nagano, T. Nakamura, T. Suzuki, N. Wadabayashi and S. Watanabe, Trends in non-melanoma skin cancer in Japan. Recent Results Cancer Res. 139, 263-273 (1995).
86. R. E. Shore, Occupational radiation studies: Status, problems, and prospects. Health Phys. 59, 63-68 (1990).
87. M. R. Karagas, J. A. McDonald, E. R. Greenberg, T. A. Stukel, J. E. Weiss, J. A. Baron and M. M. Stevens, Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J. Natl. Cancer Inst. 88, 1848-1853 (1996).
88. E. Ron, B. Modan, D. Preston, E. Alfandary, M. Stovall and J. D. Boice, Jr., Radiation-induced skin carcinomas of the head and neck. Radiat. Res. 125, 318-325 (1991).
89. J. D. Boice, Jr., D. Preston, F. G. Davis and R. R. Monson, Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat. Res. 125, 214-222 (1991).
90. G. R. Howe and J. McLaughlin, Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat. Res. 145, 694-707 (1996).
91. R. E. Shore, N. Hildreth, E. Woodard, P. Dvoretsky, L. Hempelmann and B. Pasternack, Breast cancer among women given X-ray therapy for acute postpartum mastitis. J. Natl. Cancer Inst. 77, 689-696 (1986).
92. N. G. Hildreth, R. E. Shore and P. M. Dvoretsky, The risk of breast cancer after irradiation of the thymus in infancy. N. Engl. J. Med. 321, 1281-1284 (1989).
93. A. Mattsson, B. I. Ruden, P. Hall, N. Wilking and L. E. Rutqvist, Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease. J. Natl. Cancer Inst. 85, 1679-1685 (1993).
94. M. Lundell, A. Mattsson, P. Karlsson, E. Holmberg, A. Gustafsson and L. E. Holm, Breast cancer risk after radiotherapy in infancy: A pooled analysis of two Swedish cohorts of 17,202 infants. Radiat. Res. 151, 626-632 (1999).
95. C. M. Ronckers, C. A. Erdmann and C. E. Land, Radiation and breast cancer: A review of current evidence. Breast Cancer Res. 7, 21-32 (2005).
96. M. Tokunaga, C. E. Land, S. Tokuoka, I. Nishimori, M. Soda and S. Akiba, Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat. Res. 138, 209-223 (1994).
97. D. Grady and V. L. Ernster, Endometrial cancer. In Cancer Epidemiology and Prevention (D. Schottenfeld and J. F. Fraumeni, Jr., Eds.), pp. 1058-1089. Oxford University Press, New York, 1996.
98. M. Schiffman and P. E. Castle, Human papillomavirus: Epidemiology and public health. Arch. Pathol. Lab. Med. 127, 930-934 (2003).
99. A. Ioka, H. Tsukuma, W. Ajiki and A. Oshima, Trends in uterine cancer incidence in Japan 1975-98. Jpn. J. Clin. Oncol. 33, 645-646 (2003).
100. P. G. Smith and R. Doll, Late effects of x irradiation in patients treated for metropathia haemorrhagica. Br. J. Radiol. 49, 224-232 (1976).
101. M. Ewertz and O. M. Jensen, Trends in the incidence of cancer of the corpus uteri in Denmark, 1943-1980. Am. J. Epidemiol. 119, 725-732 (1984).
102. W. D. Atkinson, D. V. Law, K. J. Bromley and H. M. Inskip, Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-97. Occup. Environ. Med. 61, 577-585 (2004).
103. A. J. Sigurdson, M. M. Doody, R. S. Rao, D. M. Freedman, B. H. Alexander, M. Hauptmann, A. K. Mohan, S. Yoshinaga, D. A. Hill and M. S. Linet, Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer 97, 3080-3089 (2003).
104. F. L. Wong, M. Yamada, H. Sasaki, K. Kodama, S. Akiba, K. Shimaoka and Y. Hosoda, Noncancer disease incidence in the atomic-bomb survivors: 1958-1986. Radiat. Res. 135, 418-430 (1993).
105. M. Yamada, F. L. Wong, S. Fujiwara, M. Akahoshi and G. Suzuki, Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat. Res. 161, 622-632 (2004).
106. S. Kawamura, F. Kasagi, K. Kodama, S. Fujiwara, M. Yamada, K. Ohama and K. Oto, Prevalence of uterine myoma detected by ultrasound examination in the atomic bomb survivors. Radiat. Res. 147, 753-758 (1997).
107. C. La Vecchia, Epidemiology of ovarian cancer: A summary review. Eur. J. Cancer Prev. 10, 125-129 (2001).
108. K. Tamakoshi, T. Kondo, H. Yatsuya, Y. Hori, F. Kikawa and H. Toyoshima, Trends in mortality (1950-1977) and incidence (1975-1993) of malignant ovarian neoplasm among Japanese women: analysis by age, time, and birth cohort. Gynecol. Oncol. 83, 64-71 (2001).
109. A. Ioka, H. Tsukuma, W. Ajiki and A. Oshima, Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci. 94, 292-296 (2003).
110. J. K. Wagoner, Leukemia and other malignancies following radiation therapy for gynecological disorders. In Radiation Carcinogenesis: Epidemiology and. Biological Significance (J. D. Boice, Jr. and J. F. Fraumeni, Jr., Eds.). Raven Press, New York, 1984.
111. S. C. Darby, G. Reeves, T. Key, R. Doll and M. Stovall, Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int. J. Cancer 56, 793-801 (1994).
112. H. A. Weiss, S. C. Darby and R. Doll, Cancer mortality following X-ray treatment for ankylosing spondylitis. Int. J. Cancer 59, 327-338 (1994).
113. S. Tokuoka, K. Kawai, Y. Shimizu, K. Inai, K. Ohe, T. Fujikura and H. Kato, Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80. J. Natl. Cancer Inst. 79, 47-57 (1987).
114. R. K. Ross and D. Schottenfeld, Prostate cancer. In Cancer Epidemiology and Prevention (D. Schottenfeld and J. F. Fraumeni, Jr., Eds.), pp. 1180-1206. Oxford University Press, New York, 1996.
115. J. K. McLaughlin, W. J. Blot, S. S. Devesa and J. F. Fraumeni, Jr., Renal cancer. In Cancer Epidemiology and Prevention (D. Schottenfeld and J. F. Fraumeni, Jr., Eds.), pp. 1142-1155. Oxford University Press, New York, 1996.
116. B. J. Drucker, Renal cell carcinoma: current status and future prospects. Cancer Treat. Rev. 31, 536-545 (2005).
117. D. T. Silverman, A. S. Morrison and S. S. Devesa, Bladder cancer. In Cancer Epidemiology and Prevention (D. Schottenfeld and J. F. Fraumeni, Jr., Eds.), pp. 1156-1179. Oxford University Press, New York, 1996.
118. P. D. Inskip, M. S. Linet and E. F. Heineman, Etiology of brain tumors in adults. Epidemiol. Rev. 17, 382-414 (1995).
119. E. Ron, B. Modan, J. D. Boice, Jr., E. Alfandary, M. Stovall, A. Chetrit and L. Katz, Tumors of the brain and nervous system after radiotherapy in childhood. N. Engl. J. Med. 319, 1033-1039 (1988).
120. P. Karlsson, E. Holmberg, M. Lundell, A. Mattsson, L. E. Holm and A. Wallgren, Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat. Res. 150, 357-364 (1998).
121. M. P. Little, F. de Vathaire, A. Shamsaldin, O. Oberlin, S. Campbell, E. Grimaud, J. Chavaudra, R. G. Haylock and C. R. Muirhead, Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int. J. Cancer 78, 269-275 (1998).
122. E. Ron, Thyroid cancer. In Cancer Epidemiology and Prevention (D. Schottenfeld and J. F. Fraumeni, Jr., Eds.), pp. 1000-1021. Oxford University Press, New York, 1996.
123. J. W. Wood, H. Tamagaki, S. Neriishi, T. Sato, W. F. Sheldon, P. G. Archer, H. B. Hamilton and K. G. Johnson, Thyroid carcinoma in atomic bomb survivors Hiroshima and Nagasaki. Am. J. Epidemiol. 89, 4-14 (1969).
124. S. Akiba, J. Lubin, E. Ezaki, E. Ron, T. Ishimaru, M. Asano, Y. Shimizu and H. Kato, Thyroid Cancer Incidence among Atomic Bomb Survivors, Hiroshima and Nagasaki, 1958-1979. Radiation Effects Research Foundation, Hiroshima, 1991.
125. E. Ron, J. H. Lubin, R. E. Shore, K. Mabuchi, B. Modan, L. M. Pottern, A. B. Schneider, M. A. Tucker and J. D. Boice, Jr., Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat. Res. 141, 259-277 (1995).
126. United Nations Scientific Committee on the Effects of Atomic Radiation, Sources, Effects, and Risks of Ionizing Radiation, with Annexes, Volume II: Effects. United Nations, New York, 2000.
127. A. Virtanen, E. Pukkala and A. Auvinen, Incidence of bone and soft tissue sarcoma after radiotherapy: A cohort study of 295,712 Finnish cancer patients. Int. J. Cancer 118, 1017-1021 (2006).